Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of catheter mediated
endocardial adenovirus-mediated vascular endothelial growth factor-D (AdVEGF-D) regenerative
gene transfer in patients with refractory angina to whom revascularisation cannot be
performed.
Phase:
Phase 2
Details
Lead Sponsor:
Kuopio University Hospital
Collaborators:
Euram Limited FinVector Vision Therapies Oy Medical University of Vienna Medizinische Universitaet Wien Queen Mary University of London Rigshospitalet, Denmark Servicio Madrileño de Salud, Madrid, Spain Śląski Uniwersytet Medyczny w Katowicach University College, London